A further analysis of the CXCR5+CD8+ T signature, which has been proposed as a possible biomarker of immunotherapy response in gastric cancer [35], showed high expression in IIH-FH tumours, while tumours belonging to the IIL-FL presented reduced expression (Fig. 5a and Supplementary Fig. 4F). This evidence concerns the gene CD8A and gastric cancer.